These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 33443863)
1. Confirmation of NKX3-1 Expression in EWSR1-NFATC2 Sarcoma and Mesenchymal Chondrosarcoma Using Monoclonal Antibody Immunohistochemistry, RT-PCR, and RNA In Situ Hybridization. Yoshida A; Hashimoto T; Ryo E; Yoshida KI; Motoi T; Yatabe Y; Mori T Am J Surg Pathol; 2021 Apr; 45(4):578-582. PubMed ID: 33443863 [No Abstract] [Full Text] [Related]
2. NKX3-1 Is a Useful Immunohistochemical Marker of EWSR1-NFATC2 Sarcoma and Mesenchymal Chondrosarcoma. Yoshida KI; Machado I; Motoi T; Parafioriti A; Lacambra M; Ichikawa H; Kawai A; Antonescu CR; Yoshida A Am J Surg Pathol; 2020 Jun; 44(6):719-728. PubMed ID: 31972596 [TBL] [Abstract][Full Text] [Related]
3. NKX3.1 a useful marker for mesenchymal chondrosarcoma: An immunohistochemical study. Syed M; Mushtaq S; Loya A; Hassan U Ann Diagn Pathol; 2021 Feb; 50():151660. PubMed ID: 33302222 [TBL] [Abstract][Full Text] [Related]
4. The diagnostic utility of cytology specimen in a case of EWSR1::NFATC2 sarcoma. Takeda N; Makise N; Kageyama H; Takahashi T; Katoh H; Odaka A; Oikawa M; Sugiyama T; Kawana H; Araki A; Kinoshita H; Hagiwara Y; Kamoda H; Yonemoto T; Itami M Virchows Arch; 2024 Mar; 484(3):533-538. PubMed ID: 38483612 [TBL] [Abstract][Full Text] [Related]
5. Expanding the Spectrum of EWSR1-NFATC2-rearranged Benign Tumors: A Common Genomic Abnormality in Vascular Malformation/Hemangioma and Simple Bone Cyst. Ong SLM; Lam SW; van den Akker BEWM; Kroon HM; Briaire-de Bruijn IH; Cleven AHG; Savci-Heijink DC; Cleton-Jansen AM; Baumhoer D; Szuhai K; Bovée JVMG Am J Surg Pathol; 2021 Dec; 45(12):1669-1681. PubMed ID: 34081036 [TBL] [Abstract][Full Text] [Related]
6. DNA methylation profiling distinguishes Ewing-like sarcoma with EWSR1-NFATc2 fusion from Ewing sarcoma. Koelsche C; Kriegsmann M; Kommoss FKF; Stichel D; Kriegsmann K; Vokuhl C; Grünewald TGP; Romero-Pérez L; Kirchner T; de Alava E; Diaz-Martin J; Hartmann W; Baumhoer D; Antonescu CR; Szuhai K; Flucke U; Dirksen U; Pfister SM; Jones DTW; Mechtersheimer G; von Deimling A J Cancer Res Clin Oncol; 2019 May; 145(5):1273-1281. PubMed ID: 30895378 [TBL] [Abstract][Full Text] [Related]
7. Sarcomas with EWSR1::Non-ETS Fusion (EWSR1::NFATC2 and EWSR1::PATZ1). Machado I; Llombart-Bosch A; Charville GW; Navarro S; Domínguez Franjo MP; Bridge JA; Linos K Surg Pathol Clin; 2024 Mar; 17(1):31-55. PubMed ID: 38278606 [TBL] [Abstract][Full Text] [Related]
8. Implementation of Copy Number Variations-Based Diagnostics in Morphologically Challenging Brcic I; Scheipl S; Bergovec M; Leithner A; Szkandera J; Sotlar K; Suda AJ; Smolle MA; Kraus T; Rosenberg AE; Liegl-Atzwanger B; Igrec J Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555836 [TBL] [Abstract][Full Text] [Related]
9. FUS-NFATC2 or EWSR1-NFATC2 Fusions Are Present in a Large Proportion of Simple Bone Cysts. Pižem J; Šekoranja D; Zupan A; Boštjančič E; Matjašič A; Mavčič B; Contreras JA; Gazič B; Martinčič D; Snoj Ž; Limpel Novak KA; Salapura V Am J Surg Pathol; 2020 Dec; 44(12):1623-1634. PubMed ID: 32991339 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of NKX2-2 expression in round cell sarcomas and other tumors with EWSR1 rearrangement: imperfect specificity for Ewing sarcoma. Hung YP; Fletcher CD; Hornick JL Mod Pathol; 2016 Apr; 29(4):370-80. PubMed ID: 26847175 [TBL] [Abstract][Full Text] [Related]
12. Skeletal EWSR1-NFATC2 sarcoma previously diagnosed as Ewing-like adamantinoma: A case report and literature review emphasizing its unique radiological features. Makise N; Yoshida KI; Iijima T; Yoshida A; Ushiku T; Ishida T Pathol Int; 2021 Sep; 71(9):614-620. PubMed ID: 34192825 [TBL] [Abstract][Full Text] [Related]
13. The NFATc2 gene is involved in a novel cloned translocation in a Ewing sarcoma variant that couples its function in immunology to oncology. Szuhai K; Ijszenga M; de Jong D; Karseladze A; Tanke HJ; Hogendoorn PC Clin Cancer Res; 2009 Apr; 15(7):2259-68. PubMed ID: 19318479 [TBL] [Abstract][Full Text] [Related]
14. EWSR1-NFATC2 Translocation-associated Sarcoma Clinicopathologic Findings in a Rare Aggressive Primary Bone or Soft Tissue Tumor. Wang GY; Thomas DG; Davis JL; Ng T; Patel RM; Harms PW; Betz BL; Schuetze SM; McHugh JB; Horvai AE; Cho SJ; Lucas DR Am J Surg Pathol; 2019 Aug; 43(8):1112-1122. PubMed ID: 30994538 [TBL] [Abstract][Full Text] [Related]
15. A novel FUS::NFATC4 fusion detected in a sarcoma with morphological features overlapping with NFATC2 sarcomas. Klubíčková N; Gross JM; Comová K; Kuruc J; Michal M Histopathology; 2024 Jan; 84(2):413-415. PubMed ID: 37813649 [No Abstract] [Full Text] [Related]
16. Clinicopathological and molecular spectrum of ewing sarcomas/PNETs, including validation of EWSR1 rearrangement by conventional and array FISH technique in certain cases. Rekhi B; Vogel U; Basak R; Desai SB; Jambhekar NA Pathol Oncol Res; 2014 Jul; 20(3):503-16. PubMed ID: 24293381 [TBL] [Abstract][Full Text] [Related]
17. Soft tissue round cell sarcoma of the abdominal wall, with EWSR1-non-ETS fusion (EWSR1-NFATC2 sarcoma): A case report and literature review emphasizing its clinical features. Tsuchie H; Umakoshi M; Hasegawa T; Nagasawa H; Okada K; Nanjyo H; Goto A; Miyakoshi N J Orthop Sci; 2024 Jan; 29(1):374-378. PubMed ID: 35430129 [No Abstract] [Full Text] [Related]
18. Detection of specific gene rearrangements by fluorescence in situ hybridization in 16 cases of clear cell sarcoma of soft tissue and 6 cases of clear cell sarcoma-like gastrointestinal tumor. Segawa K; Sugita S; Aoyama T; Kubo T; Asanuma H; Sugawara T; Ito Y; Tsujiwaki M; Fujita H; Emori M; Hasegawa T Diagn Pathol; 2018 Sep; 13(1):73. PubMed ID: 30219084 [TBL] [Abstract][Full Text] [Related]
19. NFATc2-rearranged sarcomas: clinicopathologic, molecular, and cytogenetic study of 7 cases with evidence of AGGRECAN as a novel diagnostic marker. Perret R; Escuriol J; Velasco V; Mayeur L; Soubeyran I; Delfour C; Aubert S; Polivka M; Karanian M; Meurgey A; Le Guellec S; Weingertner N; Hoeller S; Coindre JM; Larousserie F; Pierron G; Tirode F; Le Loarer F Mod Pathol; 2020 Oct; 33(10):1930-1944. PubMed ID: 32327700 [TBL] [Abstract][Full Text] [Related]
20. NKX3.1 immunohistochemistry is highly specific for the diagnosis of mesenchymal chondrosarcomas: experience in the Australian population. Ramanayake N; Vargas AC; Talbot J; Bonar F; Wong DD; Wong D; Mahar A; Karim R; Luk PP; Selinger C; Sioson L; Gill AJ; Maclean F Pathology; 2021 Oct; 53(6):705-712. PubMed ID: 33640159 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]